Cargando…
Decrease in stathmin expression by arsenic trioxide inhibits the proliferation and invasion of osteosarcoma cells via the MAPK signal pathway
Osteosarcoma (OS) is the most common type of malignant bone tumor in children and adolescents. In total, 40–50% of patients with OS experience metastasis, and thus have a poor prognosis. Our previous study demonstrated that arsenic trioxide (As(2)O(3)) combined with doxorubicin [also known as Adriam...
Autores principales: | Feng, Tao, Xu, Jun, He, Ping, Chen, Yuanyuan, Fang, Ruiying, Shao, Xuejun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5529766/ https://www.ncbi.nlm.nih.gov/pubmed/28789348 http://dx.doi.org/10.3892/ol.2017.6347 |
Ejemplares similares
-
Arsenic Trioxide Prevents Osteosarcoma Growth by Inhibition of GLI Transcription via DNA Damage Accumulation
por: Nakamura, Shunsuke, et al.
Publicado: (2013) -
Siva 1 inhibits proliferation, migration and invasion by phosphorylating Stathmin in ovarian cancer cells
por: Ma, Yifei, et al.
Publicado: (2017) -
Arsenic trioxide inhibits the proliferation of myeloma cell line through notch signaling pathway
por: Hu, Jiasheng, et al.
Publicado: (2013) -
Synergistic anti-tumor effects of arsenic trioxide and blue LED irradiation on human osteosarcoma
por: Feng, Chao, et al.
Publicado: (2019) -
Berberine enhances inhibition of glioma tumor cell migration and invasiveness mediated by arsenic trioxide
por: Lin, Tseng-Hsi, et al.
Publicado: (2008)